Interobserver variability in delineation of target volumes in head and neck cancer

Head and neck cancer (HNC) is the seventh most common cancer and cause of cancer-related death worldwide with yearly more than 500  000 new cases and 380 000 deaths [1]. HNC is usually diagnosed in a locally advanced but curable stage for which a multimodal treatment approach is preferred consisting of surgery followed by radio(chemo)therapy or radio(chemo)therapy as definitive treatment. Surgery for locally advanced tumour s can be mutilating whereas radio(chemo)therapy holds the potential for better functional outcomes but can cause treatment-related toxicity.
Source: Radiotherapy and Oncology - Category: Radiology Authors: Tags: Original Article Source Type: research